Export Products

Amtel by Pharma Lord is a powerful combination of Amlodipine and Telmisartan, formulated to manage high blood pressure (hypertension) effectively. Each pack contains 14 tablets, designed for once-daily dosing and long-term cardiovascular protection.

Amlodipine is a calcium channel blocker that relaxes blood vessels to improve blood flow, while Telmisartan is an angiotensin II receptor blocker (ARB) that helps lower blood pressure and protect the heart and kidneys. Together, they offer dual-action control for better outcomes in hypertension management.

Advantages:

• Dual-action control of high blood pressure.

• Reduces the risk of heart attack and stroke.

• Offers 24-hour blood pressure control.

• Convenient once-daily dosing.

• Manufactured by Pharma Lord with a focus on quality and efficacy.

  Usages / Indications:

  • Management of essential hypertension (high blood pressure).

  • Suitable for patients requiring combination therapy.

  • Helps reduce cardiovascular risks in hypertensive patients.

  • Supports heart and kidney protection in long-term use.

Bonvit-D by Pharma Lord is a bone health supplement containing Ossein Mineral Complex (OMC) and Vitamin D3. Each pack includes 30 tablets specially formulated to support strong bones, improve calcium absorption, and maintain overall skeletal health.

Ossein Mineral Complex is a natural source of calcium and other bone-building minerals, while Vitamin D3 enhances calcium absorption and utilization. Bonvit-D is ideal for individuals at risk of osteoporosis, bone weakness, or calcium deficiency.

Advantages:

• Supports bone formation and mineralization.

• Enhances calcium absorption with Vitamin D3.

• Helps prevent osteoporosis and bone loss.

• Ideal for elderly, postmenopausal women, and growing teens.

• Made by Pharma Lord with high-quality ingredients.

  Usages / Indications:

  • Prevention and treatment of calcium and Vitamin D3 deficiency.

  • Supports bone strength in elderly and menopausal women.

  • Aids in healthy bone development in adolescents.

  • Helps manage osteoporosis and related bone disorders.

Creslord 10mg by Pharma Lord contains Rosuvastatin Calcium, a statin medication used to lower bad cholesterol (LDL) and triglycerides while increasing good cholesterol (HDL). Each pack includes 14 tablets formulated for daily use in managing cholesterol and reducing cardiovascular risk.

Rosuvastatin works by blocking an enzyme involved in cholesterol production, helping prevent plaque buildup in arteries. Creslord 10mg is ideal for individuals with high cholesterol, heart disease risk, or a history of cardiovascular events.

Advantages:

• Effectively lowers LDL cholesterol and triglycerides.

• Increases HDL (good cholesterol) levels.

• Helps prevent heart attack and stroke.

• Supports long-term cardiovascular health.

• Manufactured under Pharma Lord rsquo;s high-quality standards.

  Usages / Indications:

  • Treatment of hypercholesterolemia (high cholesterol).

  • Management of mixed dyslipidemia.

  • Prevention of cardiovascular events in high-risk patients.

  • Supports a heart-healthy lifestyle alongside diet and exercise.

Pharma Lord proudly presents Dexlor, a trusted brand committed to providing advanced relief for acid reflux and related gastrointestinal conditions through its powerful formula of Dexlansoprazole. With a dedication to excellence and patient well-being, Dexlor offers a comprehensive solution for individuals seeking effective and long-lasting relief. At Dexlor, we understand the discomfort and disruption that acid reflux can cause in daily life. Acid reflux occurs when stomach acid flows back into the esophagus, causing heartburn, regurgitation, and other uncomfortable symptoms. Dexlansoprazole, the key ingredient in Dexlor, belongs to a class of medications known as proton pump inhibitors (PPIs). It works by reducing the production of stomach acid, providing relief from acid reflux and promoting the healing of damaged tissues in the esophagus. What sets Dexlor apart is the unwavering commitment to quality and innovation upheld by Pharma Lord. Our state-of-the-art manufacturing facility

DISCOVER Ixamib 2.3mg:

Welcome to Pharma Lord s groundbreaking innovation, Ixamib 2.3mg Formulated with precision and expertise as Ixazomib Citrate, our product represents a paradigm shift in the treatment of multiple myeloma. Discover how Ixamib 2.3mg is disrupting the status quo and paving the way for enhanced patient outcomes.rn Ixamib 2.3mg zeroes in on multiple myeloma cells with unparalleled precision, offering hope for patients with this challenging condition.rn Powered by Ixazomib Citrate, our product embodies the latest advancements in pharmaceutical science, ensuring maximum efficacy and safety. Embrace a new era of personalized therapy with Ixamib 2.3mg, tailored to meet the unique needs of each patient. Witness superior treatment outcomes with Ixamib 2.3mg, as it delivers unmatched efficacy in combating multiple myeloma and improving quality of life. At Pharma Lord, we are committed to pushing the boundaries of possibility. Join us as we redefine the landscape of multiple myeloma treatment through innovation and dedication. Discover the future of multiple myeloma treatment with Ixamib 2.3mg. Choose Pharma Lord for groundbreaking solutions and unwavering support on the journey to better health.

Discover Lenide 2.5mg:

Empowering Patients in the Battle Against Myelodysplastic Syndrome (MDS):

Welcome to Pharma Lord, where breakthroughs in pharmaceutical innovation meet compassionate patient care. We proudly present Lenide 2.5mg, a revolutionary medication designed to combat the challenges of Myelodysplastic Syndrome (MDS) head-on.

Introduction to Lenide 2.5mg:

MDS is a complex condition characterized by insufficient blood cell production, leading to anemia and other complications. Lenide 2.5mg, fortified with the potent compound Lenalidomide, emerges as a beacon of hope for patients navigating the complexities of MDS.

Addressing Anemia in MDS:

Anemia, a hallmark of MDS, presents a significant hurdle for patients, often necessitating frequent blood transfusions. Lenide 2.5mg offers a transformative solution by stimulating the production of healthy red blood cells, reducing the reliance on transfusions, and improving quality of life.

Unlocking Anticancer Potential:

Beyond its role in addressing anemia, Lenalidomide harbors remarkable anticancer properties, inhibiting angiogenesis and metastasis ;the hallmarks of cancer progression. Through Lenide 2.5mg, patients not only combat MDS-related complications but also gain an edge in the fight against cancer.

The Science Behind Lenide 2.5mg:

Backed by cutting-edge research and meticulous formulation, Lenide 2.5mg delivers precision and efficacy with every dose. By modulating endothelial cell function and targeting cancer pathways, this medication represents a paradigm shift in MDS treatment.

Pharma Lord's Commitment to Excellence:

At Pharma Lord, our dedication to innovation knows no bounds. Lenide 2.5mg exemplifies our commitment to redefining standards of care, empowering patients, and improving outcomes in MDS and beyond.

Experience the Transformation:

Join us in embracing a future of health and well-being with Lenide 2.5mg. Together, we can navigate the challenges of MDS, ushering in a new era of hope, resilience, and vitality.

With Lenide 2.5mg, the journey to wellness begins today. Trust Pharma Lord to be your partner every step of the way.

Introduction:

Unveiling Lenmid 2.5mg Pharma Lord's Breakthrough Anti-Cancer Medication

Inhibiting Angiogenesis:

Disrupting New Blood Vessel Formation: Lenmid 2.5mg effectively hampers the formation of new blood vessels, crucial for tumor growth, through its potent active ingredient, Lenalidomide.

Essential Role in Tumor Growth Inhibition: By targeting the process of angiogenesis, Lenmid 2.5mg plays a pivotal role in inhibiting tumor growth and progression.

Targeting Endothelial Cell Function: Lenalidomide exerts multiple inhibitory effects on endothelial cells, disrupting their function and impeding the development of new blood vessels, thus restricting the tumor's access to nutrients and oxygen.

Blocking Metastasis:

Preventing Cancer Spread: Lenmid 2.5mg serves as a formidable barrier against metastasis, the spread of cancer cells to distant sites within the body.

Impact on Metastasis Initiation and Progression: Through its multifaceted actions, Lenalidomide effectively blocks the initiation and progression of metastasis, ensuring the containment of cancerous cells within the primary tumor site.

Crucial Actions in Hypoxic Environments: Even in hypoxic conditions prevalent within solid tumors, Lenmid 2.5mg continues to exert its anti-cancer effects, thwarting metastasis and enhancing treatment efficacy.

Dual Action in Normoxic and Hypoxic Conditions:

Consistent Efficacy Across Various Tumor Environments: Lenmid 2.5mg demonstrates consistent efficacy in both normoxic and hypoxic tumor environments, offering a reliable treatment option for patients facing diverse cancer challenges.

Lomtin 40mg contains Lomustine, a chemotherapy medication used in the treatment of brain tumors and Hodgkin rsquo;s lymphoma. Lomustine is an alkylating agent that interferes with the growth of cancer cells, helping to slow or stop their spread.

Uses:

• Treatment of primary and metastatic brain tumors
• Treatment of Hodgkin rsquo;s lymphoma, especially when other treatments have not been successful
• Used in combination with other medications for certain cancers

Advantages:

• Effective against hard-to-treat cancers: Lomustine is specifically effective in brain tumors, which are challenging to treat with many other medications.
• Penetrates the blood-brain barrier: Lomustine has the unique ability to cross the blood-brain barrier, making it particularly useful for brain cancer treatments.
• Well-established treatment: Lomustine has been in use for years and is a trusted part of many cancer treatment protocols.
• Oral administration: Unlike many chemotherapy drugs that require IV administration, Lomtin 40mg is taken orally, offering convenience for patients.

Disadvantages:

• Side effects: Like most chemotherapy medications, Lomustine can cause a range of side effects, including nausea, vomiting, hair loss, and fatigue.
• Bone marrow suppression: Lomustine can lead to bone marrow suppression, increasing the risk of infections, anemia, and bleeding.
• Delayed toxicity: Some side effects, particularly related to bone marrow, may not appear until several weeks after treatment.
• Liver and kidney impact: Prolonged use can affect liver and kidney function, requiring regular monitoring.

Conclusion: Lomtin 40mg offers an effective option for treating challenging cancers like brain tumors and Hodgkin rsquo;s lymphoma. While it has significant benefits in combating cancer, it also comes with the potential for serious side effects that must be carefully managed by healthcare professionals.

Monib 40mg contains Mobocertinib Succinate, a targeted therapy designed specifically for the treatment of non-small cell lung cancer (NSCLC) caused by exon 20 insertion mutations in the EGFR gene. This mutation is typically associated with a poorer prognosis and resistance to standard EGFR inhibitors. Monib 40mg works by inhibiting the activity of mutated EGFR, offering a new hope for patients with this specific cancer type.

Uses:

• Treatment of advanced or metastatic NSCLC with exon 20 insertion mutations in the EGFR gene
• Effective in patients who have developed resistance to first- and second-generation EGFR inhibitors

Advantages:

• Targeted treatment: Monib 40mg is specifically designed to target exon 20 insertion mutations, offering an option for patients who do not respond to standard EGFR therapies.
• Oral administration: It can be taken orally, providing convenience compared to intravenous cancer treatments.
• Improves progression-free survival: Clinical studies have shown that Mobocertinib can improve progression-free survival in patients with difficult-to-treat NSCLC.
• Alternative for resistant cases: Especially beneficial for patients who have developed resistance to other EGFR-targeted therapies, giving them a new line of treatment.

Disadvantages:

• Side effects: Common side effects may include diarrhea, nausea, rash, and fatigue. More serious side effects like heart rhythm changes and lung problems can also occur.
• Limited patient population: Monib 40mg is only effective for NSCLC patients with the exon 20 insertion mutation, limiting its use in broader cancer cases.
• Drug interactions: Patients need to be cautious about potential interactions with other medications, especially those that affect the liver enzymes responsible for drug metabolism.
• Cost: As a targeted therapy, it may be more expensive compared to conventional chemotherapy drugs.

Conclusion: Monib 40mg (Mobocertinib Succinate) is a cutting-edge treatment option for patients with advanced NSCLC caused by exon 20 insertion mutations in the EGFR gene. While it offers significant advantages in targeting resistant cancer, patients must be aware of the potential side effects and limited scope of treatment.

Nepa 300mg + 0.5mg is a combination medication containing Netupitant and Palonosetron Hydrochloride, specifically designed to prevent nausea and vomiting caused by chemotherapy. It is typically used alongside dexamethasone to enhance its anti-nausea properties.

Netupitant works by blocking the action of a chemical in the brain called substance P, which is involved in triggering nausea and vomiting. Palonosetron, on the other hand, is a serotonin (5-HT3) receptor antagonist that prevents nausea signals from being sent to the brain. Together, these two drugs provide a strong defense against nausea, offering patients relief from one of the most challenging side effects of chemotherapy.

Advantages of Nepa 300mg + 0.5mg:

1. Highly Effective: By combining two powerful anti-nausea agents, Nepa offers superior protection against chemotherapy-induced nausea and vomiting (CINV).
2. Long-Lasting Relief: The effects of Palonosetron last longer than other 5-HT3 receptor antagonists, reducing the need for frequent dosing.
3. Convenient: The oral formulation allows for easier administration, reducing the need for IV anti-nausea drugs.
4. Prevents Both Acute and Delayed Nausea: It protects against both the immediate and delayed phases of CINV, giving comprehensive coverage.
5. Fewer Repeat Doses: Nepa can reduce the need for additional anti-nausea medication in the days following chemotherapy, as it remains effective for an extended period.

Disadvantages of Nepa 300mg + 0.5mg:

1. Potential Side Effects: Like all medications, it may cause side effects such as headache, constipation, fatigue, and weakness.
2. Not Suitable for All Patients: Some patients, such as those with severe liver or kidney issues, may need to avoid or adjust the dose of Nepa.
3. Interactions with Other Drugs: The combination with dexamethasone may increase the risk of certain side effects, and Nepa can interact with other medications, so medical supervision is required.
4. Cost: Due to its specialized formulation, it may be more expensive compared to other anti-nausea medications.

Nepa 300mg + 0.5mg provides a powerful solution for patients undergoing chemotherapy, helping them maintain their quality of life by effectively managing nausea and vomiting.

Product Name: Nfen 50mg
Composition: Diclofenac Sodium
Manufacturer: Pharma Lord (Pvt.) Ltd

Nfen 50mg contains Diclofenac Sodium, a nonsteroidal anti-inflammatory drug (NSAID) that is used to relieve pain, inflammation, and swelling. It works by inhibiting the production of prostaglandins, chemicals in the body that promote inflammation. Nfen 50mg is commonly used to treat conditions such as arthritis, muscle pain, and post-surgical pain, providing effective relief from discomfort.

Advantages:

1. Effective in reducing pain, inflammation, and swelling.

2. Ideal for conditions like arthritis, muscle pain, and post-surgical recovery.

3. Fast-acting formula for quick pain relief.

4. Available in a convenient tablet form for easy dosing.

5. Manufactured with high-quality standards by Pharma Lord (Pvt.) Ltd.

Usage:

Nfen 50mg is used for:

• Treating pain and inflammation caused by arthritis (osteoarthritis, rheumatoid arthritis).
• Reducing pain from injuries, muscle strains, and sprains.
• Providing post-operative pain relief.
• Managing pain from conditions such as gout or dental surgeries.

Dosage:

• Adults: Typically, 50mg twice daily, or as prescribed by a physician, depending on the severity of the condition.
• Children: The dosage is based on age and weight, as recommended by a healthcare provider.
• Take the tablet with food or milk to reduce gastrointestinal discomfort.

Important: Follow the prescribed dosage and do not exceed the recommended dose. Consult a healthcare provider before use, especially if you have a history of gastrointestinal issues or other medical conditions.

Active Ingredient: Niraparib Tosylate Monohydrate

Nirib 100mg is a targeted therapy for adult patients with ovarian epithelial, fallopian tube, or primary peritoneal cancer. This advanced treatment works by inhibiting an enzyme essential for numerous cellular functions, including the repair of damaged DNA. By blocking this enzyme, Nirib 100mg helps prevent the growth and spread of cancer cells, making it an effective choice in specific cancer therapies. Niraparib Tosylate Monohydrate is also being researched for its potential in treating other types of cancer.

Indication:

• Ovarian Epithelial Cancer
• Fallopian Tube Cancer
• Primary Peritoneal Cancer

Mechanism of Action:
Nirib 100mg targets and inhibits DNA repair mechanisms in cancer cells, limiting their ability to survive and proliferate.

Advantages:

1. Targeted Cancer Therapy:

   • Nirib 100mg specifically targets and blocks the PARP enzyme, which plays a crucial role in repairing damaged DNA in cancer cells. This makes the treatment more precise and effective for certain cancer types.

2. Effective for Multiple Cancer Types:

   • It is approved for treating ovarian epithelial, fallopian tube, and primary peritoneal cancers, offering versatility in cancer management.

3. Oral Administration:

   • Nirib 100mg is available in tablet form, allowing patients the convenience of oral administration at home rather than requiring hospital visits for IV infusions.

4. Potential for Broader Applications:

   • Niraparib Tosylate Monohydrate is currently being studied for use in other types of cancers, which could expand its use in future cancer treatments.

5. Slows Cancer Progression:

   • Clinical studies have shown that Nirib 100mg can significantly delay disease progression, improving quality of life for patients by extending progression-free survival.

Disadvantages:

1. Side Effects:

   • Common side effects include nausea, fatigue, anemia, and thrombocytopenia (low platelet counts), which can impact patients' quality of life during treatment.

2. Not Suitable for All Cancer Types:

   • While effective for certain cancers, Nirib 100mg is not suitable for all cancer types, limiting its application to specific indications.

3. Potential for Resistance:

   • Over time, cancer cells may develop resistance to PARP inhibitors, which could reduce the effectiveness of the drug in long-term treatment.

4. High Cost:

   • As with many cancer treatments, Nirib 100mg can be expensive, and affordability might be an issue for some patients, depending on their healthcare coverage.

5. Risk of Severe Complications:

   • Serious side effects, though less common, may include bone marrow suppression, gastrointestinal issues, and cardiovascular problems, which require close monitoring by healthcare professionals.

Dosage Form: 100mg Tablets

Consult your healthcare provider for detailed dosage instructions and to understand potential side effects.

Nitrogrin 2.6mg by Pharma Lord contains Nitroglycerine, a well-established medication used to prevent and manage chest pain (angina) in patients with coronary artery disease. Each pack contains 14 tablets designed for sustained relief and easy administration.

Nitroglycerine works by relaxing and widening blood vessels, improving blood flow to the heart, and reducing the heart's workload. This helps prevent episodes of angina and allows patients to maintain a more active lifestyle with fewer interruptions due to chest pain.

Advantages:

• Provides effective relief from angina (chest pain).

• Enhances oxygen delivery to the heart.

• Helps improve exercise tolerance in heart patients.

• Convenient dosage form for regular use.

• Manufactured under strict quality standards by Pharma Lord.

Usages / Indications:

• Prophylactic treatment of chronic stable angina pectoris.

• Helps in reducing the frequency and severity of anginal attacks.

• Used in patients with ischemic heart disease to improve heart function.

Active Ingredient: Olaparib

Olarib 50mg contains Olaparib, a targeted chemotherapy drug used to treat specific types of cancer, including ovarian, breast, pancreatic, and prostate cancers. This treatment works by inhibiting certain enzymes in cancer cells, preventing their growth and replication. By focusing on cancer cell mechanisms, Olarib offers a more precise approach to cancer treatment, potentially improving patient outcomes.

Indications:

• Ovarian Cancer
• Breast Cancer
• Pancreatic Cancer
• Prostate Cancer

Mechanism of Action:
Olarib 50mg works by inhibiting the enzyme PARP (poly ADP-ribose polymerase), which is essential for repairing damaged DNA in cancer cells. By blocking this enzyme, cancer cells struggle to repair themselves, leading to cell death and preventing tumor growth.

Dosage Form: 50mg Tablets

Advantages of Olarib 50mg:

1. Targeted Cancer Therapy:
   • Olarib specifically targets the PARP enzyme, making the treatment more effective in cancers with BRCA1 or BRCA2 gene mutations.
2. Multiple Cancer Applications:
   • It is approved for treating various types of cancers including ovarian, breast, pancreatic, and prostate cancers, providing versatility in cancer management.
3. Improves Survival Rates:
   • Studies have shown that Olaparib can improve progression-free survival rates, particularly in patients with certain genetic mutations, helping to delay cancer recurrence.
4. Oral Administration:
   • Available in tablet form, allowing patients the convenience of at-home administration instead of intravenous treatments at hospitals.
5. Potential for Long-Term Disease Control:
   • In some cases, it can significantly reduce the risk of cancer progression, offering long-term disease control.

Disadvantages of Olarib 50mg:

1. Side Effects:
   • Common side effects include nausea, vomiting, fatigue, and anemia. In some cases, more severe side effects such as bone marrow suppression and respiratory problems may occur.
2. Not Suitable for All Patients:
   • While it is effective for cancers with specific genetic mutations, it may not work as well in patients without these mutations, limiting its efficacy in some cases.
3. Resistance Development:
   • Over time, cancer cells can develop resistance to PARP inhibitors like Olaparib, reducing its effectiveness for long-term use.
4. Cost:
   • As with many cancer treatments, Olarib can be expensive, and not all patients may have access to it due to financial constraints or healthcare coverage limitations.
5. Potential Serious Complications:
   • Rare but serious side effects include the development of myelodysplastic syndrome or acute myeloid leukemia, requiring close monitoring during treatment.

Active Ingredient: Olutasidenib

Olunib 150mg is a targeted therapy designed for the treatment of acute myeloid leukemia (AML) in patients with a specific isocitrate dehydrogenase-1 (IDH-1) mutation. This medication is intended for patients whose AML has either returned or has not responded to prior treatments. By inhibiting the IDH-1 enzyme, Olunib 150mg works to slow or stop the growth of leukemia cells, providing a potential option for patients with this challenging condition.

Indication:

• Acute Myeloid Leukemia (AML) with IDH-1 mutation (relapsed or refractory)

Mechanism of Action:
Olunib 150mg specifically targets the mutated IDH-1 enzyme, which is responsible for producing an abnormal protein that contributes to cancer cell growth. By inhibiting this enzyme, Olunib helps restore normal cell function and reduce the proliferation of leukemia cells.

Dosage Form: 150mg Tablets

Prescription Requirement:
This medicine is available only through a prescription, and patients must undergo testing to confirm the presence of the IDH-1 mutation before starting treatment.

Active Ingredient: Pacritinib Citrate

Pacnib 100mg is a specialized treatment designed for adults with intermediate-risk or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF, and post-essential thrombocythemia MF. This medication is particularly useful for patients who suffer from very low blood platelet counts (thrombocytopenia). By inhibiting certain enzymes that contribute to the progression of myelofibrosis, Pacnib 100mg helps to reduce symptoms and improve overall health outcomes in these patients.

Indications:

• Intermediate-risk or high-risk Myelofibrosis (MF)
• Primary Myelofibrosis (MF)
• Post-polycythemia vera Myelofibrosis (MF)
• Post-essential thrombocythemia Myelofibrosis (MF)

Mechanism of Action:
Pacnib 100mg works by inhibiting JAK2 and FLT3 enzymes, which play a key role in the abnormal production of blood cells associated with myelofibrosis. This helps in managing symptoms and slowing the progression of the disease, especially in patients with low platelet counts.

Dosage Form: 100mg Tablets

Prescription Requirement:
Pacnib 100mg is available by prescription and is tailored for patients with specific blood and platelet conditions, under the guidance of a healthcare professional.

Advantages of Pacnib 100mg:

1. Effective for Low Platelet Count Patients:

   • Pacnib 100mg is specifically designed for patients with myelofibrosis who also suffer from thrombocytopenia (very low platelet counts), making it a suitable option where other treatments may not be appropriate.

2. Targeted Action:

   • By inhibiting JAK2 and FLT3 enzymes, the drug directly addresses the underlying causes of abnormal blood cell production, helping to manage and control the progression of myelofibrosis.

3. Improves Symptoms:

   • Pacnib 100mg can help reduce the severity of symptoms like spleen enlargement, fatigue, and bone marrow scarring, improving patients rsquo; quality of life.

4. Addresses Multiple Types of Myelofibrosis:

   • It is effective across various forms of myelofibrosis, including primary, post-polycythemia vera, and post-essential thrombocythemia myelofibrosis, offering flexibility in treatment.

5. Oral Administration:

   • Available in tablet form, Pacnib 100mg offers the convenience of oral administration, allowing patients to manage their treatment from home.

Active Ingredient: Palbociclib

Palib 100mg contains Palbociclib, a targeted therapy used to treat advanced or metastatic breast cancer. It works by inhibiting certain enzymes known as CDK4 and CDK6, which are responsible for regulating cell division. By blocking these enzymes, Palib 100mg helps to slow or stop the growth of cancer cells, particularly in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancers.

Indications:

• Advanced or metastatic breast cancer (HR+/HER2-)

Mechanism of Action:
Palib 100mg works by inhibiting the activity of cyclin-dependent kinases (CDK4 and CDK6), which are crucial in cell division. This action slows the progression of cancer by preventing cancer cells from multiplying.

Dosage Form: 100mg Tablets

Prescription Requirement:
Palib 100mg is available by prescription and should be used under the supervision of a healthcare provider who will monitor its effects and adjust the dosage as necessary.

Advantages of Palib 100mg:

1. Targeted Therapy:

   • Palib 100mg specifically targets CDK4 and CDK6 enzymes that contribute to cancer cell growth, offering a more focused approach in treating certain types of breast cancer.

2. Improves Progression-Free Survival:

   • Studies have shown that Palbociclib significantly extends progression-free survival in patients with advanced breast cancer, helping them manage their disease for longer periods without progression.

3. Effective in Combination Therapy:

   • Palib 100mg is often used in combination with hormone therapies such as letrozole or fulvestrant, which enhances its effectiveness in treating HR+/HER2- breast cancer.

4. Oral Administration:

   • Palib 100mg is administered in tablet form, making it easy for patients to take the treatment at home without the need for hospital visits for injections or IV infusions.

5. Delays Need for Chemotherapy:

   • By slowing cancer progression, Palib 100mg can delay the need for chemotherapy, improving patients' quality of life and reducing exposure to the side effects associated with traditional chemotherapy.

Pexnib 125mg, containing Pexidartinib Hydrochloride, is a medication manufactured by Pharma Lord. It is primarily used for the treatment of tenosynovial giant cell tumor (TGCT), a rare, non-cancerous tumor that affects the synovium (the lining of the joints and tendons). TGCT can cause joint pain, stiffness, and swelling, which may limit mobility. Pexidartinib Hydrochloride is a tyrosine kinase inhibitor that works by blocking certain proteins (CSF1R, KIT, and FLT3) involved in the abnormal cell growth contributing to TGCT.

Advantages:

• Targeted Therapy: Pexnib specifically targets the CSF1R protein, which is crucial for TGCT cell survival, making it an effective treatment for patients with locally advanced or recurrent TGCT that cannot be cured with surgery.
• Non-Surgical Option: For patients whose tumors are inoperable or surgery poses significant risks, Pexnib offers a non-invasive treatment alternative.
• Improved Mobility: By reducing tumor size and alleviating symptoms like pain and stiffness, Pexnib can improve joint function and mobility.
• Disease Control: Pexnib may help control the progression of TGCT, providing relief from symptoms over the long term.

Uses:

• Treatment of tenosynovial giant cell tumor (TGCT) in adults with severe cases where surgical removal is not a viable option.
• Management of TGCT symptoms such as joint pain, swelling, and stiffness.
• Potential reduction in tumor size and prevention of further damage to joints or tendons.

As always, patients should follow their healthcare provider's recommendations when using Pexnib 125mg. Regular monitoring of liver function is important due to the potential side effects of the drug.

Pomid 1mg, containing Pomalidomide, is a potent immunomodulatory drug manufactured by Pharma Lord. It is primarily used in the treatment of multiple myeloma, a type of cancer that forms in plasma cells. Pomalidomide is similar to thalidomide and lenalidomide, but it has been modified to improve its effectiveness and reduce side effects. This medication works by affecting the immune system, reducing inflammation, and stopping the growth of cancerous cells in the bone marrow.

Advantages:

• Effective in Relapsed or Refractory Multiple Myeloma: Pomid is often used in combination with other therapies for patients who have already tried two or more treatments (including lenalidomide and a proteasome inhibitor) without success.
• Immunomodulatory Action: Pomalidomide enhances immune system activity to help the body fight cancer cells more effectively.
• Anti-Cancer Properties: It inhibits the growth of myeloma cells and may also block the blood vessels that supply the tumor, helping to slow disease progression.
• Improved Survival: Clinical studies have shown that pomalidomide, in combination with other medications such as dexamethasone, can increase survival rates in patients with multiple myeloma who have relapsed or are resistant to prior treatments.

Uses:

• Treatment of relapsed or refractory multiple myeloma in patients who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor, and have shown disease progression on or within 60 days of completion of the last therapy.
• Enhances the body rsquo;s immune response to better control the growth and spread of cancer cells.
• Can be used in combination with other medications (e.g., dexamethasone) for a more effective treatment regimen.

Patients should be monitored closely for potential side effects, including low blood cell counts, and follow their healthcare provider's instructions carefully when using Pomid 1mg.

Pranib 100mg, containing Pralsetinib, is an advanced cancer therapy manufactured by Pharma Lord. Pralsetinib is a selective RET (rearranged during transfection) inhibitor used for the treatment of specific cancers driven by RET gene mutations or fusions. This includes certain types of non-small cell lung cancer (NSCLC), medullary thyroid cancer (MTC), and other RET-altered thyroid cancers. By targeting the abnormal RET proteins that fuel cancer growth, Pranib offers a precise, targeted treatment option for patients with RET-driven tumors.

Advantages:

• Targeted Therapy for RET Mutations: Pranib is specifically designed to inhibit RET gene mutations and fusions, making it a highly effective treatment for patients with cancers driven by these alterations.
• Broader Application Across Cancer Types: It is used in the treatment of non-small cell lung cancer (NSCLC) and RET-mutant thyroid cancers, including medullary thyroid cancer (MTC), providing flexibility across different cancers.
• Potential for Improved Outcomes: Clinical studies have shown that Pralsetinib can significantly shrink tumors and slow disease progression, leading to better outcomes in patients with RET-driven cancers.
• Reduced Side Effects Compared to Chemotherapy: As a targeted therapy, Pranib is designed to affect cancer cells with RET alterations while minimizing damage to normal cells, leading to fewer side effects compared to traditional chemotherapy.

Uses:

• Treatment of RET fusion-positive non-small cell lung cancer (NSCLC) in adult patients.
• Treatment of RET-mutant medullary thyroid cancer (MTC) in patients requiring systemic therapy.
• Treatment of RET fusion-positive thyroid cancer in patients who require systemic therapy and are refractory to radioactive iodine (if appropriate).

Pranib 100mg provides a critical option for cancer patients whose tumors are driven by RET gene alterations, offering a more precise and potentially more effective treatment compared to conventional therapies.

Prolol 60mg (Propranolol Hydrochloride) is a beta-blocker medication manufactured by Pharma Lord. It is commonly used to manage a variety of cardiovascular conditions and related disorders. Propranolol works by blocking beta-adrenergic receptors, reducing the effects of adrenaline on the heart and blood vessels, which helps to regulate heart rate, blood pressure, and overall cardiovascular function.

Advantages of Prolol 60mg:

1. Control of Hypertension: Prolol helps lower high blood pressure, reducing the risk of heart attacks, strokes, and kidney problems.
2. Prevention of Heart Attacks: By managing heart rhythm and reducing stress on the heart, Prolol can lower the chance of heart attacks in high-risk patients.
3. Relief from Anxiety: It is effective in treating anxiety and stage fright by reducing physical symptoms such as rapid heartbeat, shaking, and sweating.
4. Migraine Prevention: Prolol can prevent the frequency and severity of migraines, making it suitable for long-term migraine management.
5. Management of Angina (Chest Pain): It helps to relieve chest pain by decreasing the heart rsquo;s demand for oxygen.
6. Control of Irregular Heartbeats: It stabilizes abnormal heart rhythms, improving heart efficiency and reducing symptoms like dizziness and shortness of breath.

Uses of Prolol 60mg:

• High Blood Pressure (Hypertension): Helps reduce blood pressure and prevent complications related to hypertension.
• Angina: Used in the management of chronic chest pain due to reduced blood flow to the heart.
• Heart Attack Prevention: Prolol is prescribed to reduce the risk of heart attacks in individuals with a history of cardiovascular issues.
• Arrhythmias (Irregular Heartbeats): It helps to regulate heartbeats and prevent complications associated with arrhythmias.
• Migraine Prevention: Provides long-term control over migraine headaches.
• Anxiety Management: Useful for reducing physical symptoms of anxiety in social situations or public speaking.
• Thyroid Storm: Can be used to manage symptoms of hyperthyroidism and prevent a thyroid storm, a life-threatening condition.

This versatile beta-blocker is widely used in clinical settings to address various cardiovascular and stress-related conditions.

Pharma Lord proudly presents Prolord, a leading brand committed to providing trusted relief through the powerful formula of Paracetamol. With a dedication to excellence and patient well-being, Prolord offers a reliable solution for managing pain and reducing fever. At Prolord, we understand the impact that pain and fever can have on daily life. Whether it s a headache, muscle ache, or symptoms associated with cold and flu, these discomforts can hinder productivity and diminish overall well-being. With Paracetamol as its core ingredient, Prolord provides a proven and effective solution for quick relief. Paracetamol, a widely recognized analgesic and antipyretic, works by inhibiting the production of certain chemicals in the body that cause pain and fever. By addressing the underlying causes, Prolord helps individuals find comfort and regain control of their lives, allowing them to focus on what matters most. What sets Prolord apart is the unwavering commitment to quality and innovation

Prozin 50mg (Procarbazine Hydrochloride) is an antineoplastic (anti-cancer) medication manufactured by Pharma Lord. It belongs to the class of drugs known as alkylating agents, which interfere with the growth of cancer cells by preventing their ability to divide and multiply. Prozin 50mg is primarily used in combination with other medications to treat various types of cancer, especially Hodgkin's lymphoma.

Advantages of Prozin 50mg:

1. Effective in Cancer Treatment: Prozin has shown significant success in treating Hodgkin's lymphoma and other types of cancers, slowing the growth of cancer cells.
2. Combination Therapy: Often used as part of combination chemotherapy regimens, Procarbazine enhances the effectiveness of other cancer-fighting drugs.
3. Selective Action on Cancer Cells: Prozin targets rapidly dividing cancer cells, reducing tumor growth and spread, which makes it a vital part of chemotherapy protocols.
4. Improved Survival Rates: When used as part of a comprehensive treatment plan, it has been linked to improved survival outcomes in patients with Hodgkin rsquo;s lymphoma.
5. Crosses the Blood-Brain Barrier: This property makes Prozin effective in treating cancers affecting the central nervous system (CNS), such as brain tumors.

Uses of Prozin 50mg:

• Hodgkin's Lymphoma: Prozin is commonly used in combination with other chemotherapeutic agents to treat this type of cancer affecting the lymphatic system.
• Non-Hodgkin's Lymphoma: In some cases, Procarbazine is used to treat other lymphomas as part of chemotherapy regimens.
• Brain Tumors: It is effective in treating certain types of brain cancers, including gliomas, due to its ability to cross the blood-brain barrier.
• Malignant Melanoma: Occasionally, Procarbazine is used in the treatment of malignant melanoma, particularly in advanced stages.
• Combination Chemotherapy: Prozin is often part of the MOPP regimen (Mechlorethamine, Vincristine, Procarbazine, Prednisone) for Hodgkin rsquo;s lymphoma, demonstrating its synergy with other anticancer drugs.

Prozin 50mg provides an essential tool in the treatment of aggressive cancers by disrupting cancer cell growth and contributing to more effective treatment protocols, especially when used as part of combination therapies.

Selpernib 40mg (Selpercatinib) is a targeted cancer therapy manufactured by Pharma Lord. Selpercatinib is a RET kinase inhibitor, specifically designed to target cancers with RET (rearranged during transfection) gene mutations or fusions. By selectively inhibiting RET signaling pathways, Selpernib slows down or stops the growth of cancer cells in certain types of cancers, particularly non-small cell lung cancer (NSCLC) and medullary thyroid cancer (MTC).

Advantages of Selpercatinib:

1. Precision Targeting of RET Mutations: Selpercatinib is highly effective in treating cancers that exhibit RET mutations or fusions, ensuring more efficient and focused treatment with fewer effects on healthy cells.
2. Oral Administration: The medication is taken orally, providing a more convenient treatment option compared to traditional intravenous chemotherapy.
3. Durable Response: Clinical studies have shown that Selpercatinib provides long-lasting responses in patients with RET-altered cancers, improving the overall prognosis.
4. Effective Across Multiple Cancer Types: Besides its efficacy in RET-mutated NSCLC and medullary thyroid cancer, Selpercatinib shows promise in other RET-driven cancers, including papillary thyroid cancer.
5. Improved Quality of Life: By specifically targeting cancer cells, Selpercatinib reduces the likelihood of severe side effects commonly associated with broader-acting chemotherapy drugs, leading to a better quality of life for patients.
6. Good Tolerance: Patients generally tolerate Selpercatinib well, with manageable side effects, even when used for long-term treatment.

Uses of Selpernib 40mg:

• Non-Small Cell Lung Cancer (NSCLC): Selpernib is used to treat RET fusion-positive NSCLC in patients whose cancer has spread or is unresectable.
• Medullary Thyroid Cancer (MTC): It is prescribed for patients with RET-mutant MTC, particularly those who are advanced or have metastasized, and cannot undergo surgery.
• Papillary Thyroid Cancer: Selpernib is also effective in treating RET fusion-positive papillary thyroid cancer in cases where radioactive iodine treatment has failed or is inappropriate.
• RET-Altered Solid Tumors: In addition to lung and thyroid cancers, Selpernib may be used in patients with other RET-altered solid tumors that do not have satisfactory alternative treatments.

Selpernib 40mg offers a modern, targeted approach to cancer therapy, improving outcomes for patients with RET-driven cancers, making it a valuable treatment option in precision oncology.

Selunib 10mg (Selumetinib Sulfate) is a targeted cancer therapy manufactured by Pharma Lord. Selumetinib Sulfate is a MEK inhibitor that blocks the activity of the MEK enzymes involved in cell growth and survival. By inhibiting these pathways, Selumetinib Sulfate effectively slows down or stops the growth of certain cancer cells, particularly in neurofibromatosis type 1 (NF1)-associated tumors and other cancers driven by abnormal MEK activity.

Advantages of Selumetinib Sulfate:

1. Targeted MEK Inhibition: Selumetinib specifically targets the MEK1 and MEK2 proteins, crucial in the signaling pathways that promote cancer cell growth, providing a highly targeted approach to treatment.
2. Non-Invasive Oral Therapy: Administered orally, Selunib offers a more convenient treatment option, avoiding the need for intravenous chemotherapy.
3. Effectiveness in NF1-Related Tumors: Selumetinib is the first FDA-approved treatment for neurofibromatosis type 1, significantly reducing the size of plexiform neurofibromas (benign tumors) in children.
4. Promising Results in Other Tumors: It shows efficacy in treating other cancers, including some forms of thyroid cancer and melanoma, when used in combination with other therapies.
5. Slowing Tumor Progression: Selumetinib not only shrinks tumors but also slows their progression, providing long-term management for certain cancers.
6. Reduced Side Effects: Compared to traditional chemotherapy, Selumetinib offers a more targeted approach, potentially resulting in fewer and less severe side effects.

Uses of Selunib 10mg:

• Neurofibromatosis Type 1 (NF1): Selunib is primarily used to treat symptomatic, inoperable plexiform neurofibromas in children with NF1.
• Thyroid Cancer: It is used in combination therapies to treat advanced thyroid cancers, particularly in patients resistant to standard treatments.
• Melanoma: Selumetinib shows promise when used in combination with other agents to treat advanced-stage melanoma with specific genetic mutations.
• Other Solid Tumors: Selumetinib is being investigated for use in various solid tumors that involve abnormal MEK signaling pathways.

Songib 200mg (Sonidegib) is an oral cancer therapy manufactured by Pharma Lord. Sonidegib is a Hedgehog pathway inhibitor, specifically targeting and blocking the Hedgehog signaling pathway, which is abnormally activated in certain cancers. By inhibiting this pathway, Sonidegib helps to prevent the growth and spread of cancer cells, particularly in advanced basal cell carcinoma (BCC).

Advantages of Sonidegib:

1. Targeted Action on Cancer Cells: Sonidegib selectively inhibits the Hedgehog signaling pathway, making it effective in treating cancers with this pathway's abnormal activation, such as basal cell carcinoma.
2. Effective for Advanced Basal Cell Carcinoma (BCC): It is highly effective for patients with locally advanced BCC or metastatic BCC who are not suitable for surgery or radiation.
3. Oral Administration: The convenience of oral dosing allows patients to undergo treatment without the need for frequent hospital visits, improving patient compliance.
4. Potential for Fewer Side Effects: Compared to conventional chemotherapy, Sonidegib rsquo;s targeted mechanism of action may result in fewer off-target effects and lower toxicity.
5. Long-Term Tumor Control: It provides sustained control over the progression of basal cell carcinoma, making it suitable for long-term use in patients with advanced cases.

Uses of Songib 200mg:

• Locally Advanced Basal Cell Carcinoma: Used in patients whose BCC cannot be treated with surgery or radiation.
• Metastatic Basal Cell Carcinoma: For patients with BCC that has spread to other parts of the body and is not responsive to standard treatments.
• Other Hedgehog Pathway-Activated Cancers: Sonidegib is being researched for its efficacy in other cancers driven by abnormal Hedgehog pathway signaling.

Spifur by Pharma Lord is a powerful diuretic combination of Spironolactone and Furosemide, designed to manage fluid retention (edema) and treat conditions like hypertension, heart failure, and liver or kidney disorders. Each pack contains 14 tablets for convenient dosing.

Spironolactone is a potassium-sparing diuretic that prevents the body from losing too much potassium, while Furosemide is a loop diuretic that helps eliminate excess fluid and salt from the body. Together, they offer effective fluid balance management without significant electrolyte imbalances.

Advantages:

• Combines two effective diuretics in one tablet.

• Reduces fluid retention and swelling (edema).

• Supports management of high blood pressure and heart failure.

• Maintains potassium levels while promoting fluid excretion.

• Manufactured by Pharma Lord with a commitment to quality and safety.

  Usages / Indications:

  • Treatment of edema associated with congestive heart failure, liver cirrhosis, or kidney disease.

  • Management of hypertension (high blood pressure).

  • Helps reduce fluid overload in patients with heart or kidney conditions.

  • Supports long-term control of chronic fluid imbalance.

Sunib 12.5mg (Sunitinib Malate) is a targeted cancer therapy manufactured by Pharma Lord. Sunitinib Malate is a multi-kinase inhibitor that works by blocking multiple enzymes involved in the growth, replication, and spread of cancer cells. This oral medication is used to treat several types of cancer, particularly renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET).

Advantages of Sunitinib Malate:

1. Multi-Targeted Action: Sunitinib inhibits multiple receptor tyrosine kinases (RTKs), which are responsible for tumor growth, angiogenesis (new blood vessel formation), and metastasis.
2. Effective in Multiple Cancer Types: It is proven effective in treating several difficult-to-treat cancers, such as advanced kidney cancer, GIST, and pNET.
3. Oral Treatment: Administered orally, making it convenient for patients as it avoids frequent hospital visits for injections or infusions.
4. Slows Tumor Growth: Sunitinib not only inhibits tumor growth but also prevents new blood vessels from supplying the tumor, effectively starving it of the nutrients it needs to grow.
5. Prolonged Survival: It has shown the ability to extend survival in patients with metastatic renal cell carcinoma and other advanced cancers.
6. Potential for Combination Therapy: Sunitinib is also being explored for use in combination with other therapies to enhance overall treatment efficacy.

Uses of Sunib 12.5mg:

• Renal Cell Carcinoma (RCC): Used for the treatment of advanced kidney cancer (RCC), particularly in cases where surgery is not an option.
• Gastrointestinal Stromal Tumors (GIST): Prescribed for patients with GIST who are resistant to or cannot tolerate imatinib (another cancer therapy).
• Pancreatic Neuroendocrine Tumors (pNET): Effective in treating advanced pNET, especially in patients with inoperable or metastatic disease.
• Other Tumor Types: Investigated for its potential in treating other tumors driven by abnormal RTK signaling.

Talrib 0.25mg (Talazoparib Tosylate) is a potent PARP inhibitor manufactured by Pharma Lord. Talazoparib works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which is involved in DNA repair. Cancer cells with BRCA1 or BRCA2 mutations rely on PARP to repair their damaged DNA and survive. By blocking PARP, Talazoparib prevents cancer cells from repairing their DNA, leading to cell death, making it a powerful treatment for certain types of cancers, especially breast cancer.

Advantages of Talazoparib Tosylate:

1. Targeted Therapy for BRCA-Mutated Cancers: Talazoparib is especially effective in treating cancers with BRCA1 or BRCA2 mutations, making it a precision treatment option for patients with these genetic profiles.
2. Dual Mechanism of Action: Besides inhibiting PARP, Talazoparib also traps PARP enzymes at the site of DNA damage, further enhancing its anticancer effects.
3. Oral Administration: Taken orally, providing a convenient alternative to intravenous cancer treatments, allowing patients to take the medication at home.
4. Improved Progression-Free Survival: Studies show that Talazoparib significantly extends the time without cancer progression in patients with advanced breast cancer.
5. Well-Tolerated: Patients generally tolerate Talazoparib well, with manageable side effects compared to more aggressive treatments like chemotherapy.
6. Potential for Combination Therapies: Talazoparib is being explored for use in combination with other cancer treatments to enhance overall efficacy.

Uses of Talrib 0.25mg:

• Breast Cancer: Talazoparib is used for the treatment of adults with HER2-negative locally advanced or metastatic breast cancer with germline BRCA mutations.
• Ovarian, Pancreatic, and Prostate Cancers: Being investigated and used in certain clinical settings for BRCA-mutated ovarian, pancreatic, and prostate cancers.
• DNA Repair Deficient Tumors: It shows potential in treating cancers with defects in DNA repair mechanisms, particularly in tumors reliant on PARP for survival.

Temid 5mg (Temozolomide) is an oral chemotherapy medication manufactured by Pharma Lord, indicated for the treatment of certain types of brain tumors, particularly glioblastoma multiforme (GBM) and anaplastic astrocytoma. Temozolomide works by alkylating DNA, leading to cell death in cancerous cells and ultimately inhibiting tumor growth.

Advantages of Temozolomide:

1. Effective for High-Grade Brain Tumors: Temozolomide is a first-line treatment for glioblastoma multiforme, significantly improving patient survival rates when used in combination with radiation therapy.
2. Oral Administration: As an oral medication, it offers convenience for patients, allowing for home administration rather than requiring intravenous therapy.
3. Flexible Dosing Schedule: Temozolomide can be administered in various dosing schedules, tailored to the patient's specific treatment plan.
4. Penetrates the Blood-Brain Barrier: It effectively crosses the blood-brain barrier, which is crucial for treating brain tumors.
5. Potential for Combination Therapy: Often used alongside radiotherapy or other chemotherapeutic agents to enhance overall effectiveness.
6. Manageable Side Effects: While it can cause side effects, many patients find the side effects manageable compared to other more aggressive chemotherapy options.

Uses of Temid 5mg:

• Glioblastoma Multiforme (GBM): Primarily used for newly diagnosed GBM patients, particularly in conjunction with radiation therapy.
• Anaplastic Astrocytoma: Effective in treating patients with recurrent anaplastic astrocytoma.
• Maintenance Therapy: May be used as a maintenance treatment after initial therapy to prolong survival and delay tumor progression.

Thamid 50mg (Thalidomide) is an immunomodulatory agent manufactured by Pharma Lord, known for its role in treating multiple myeloma and complications of leprosy (erythema nodosum leprosum). Thalidomide works by inhibiting the production of tumor necrosis factor-alpha (TNF- alpha;) and modifying the immune system rsquo;s response, leading to its efficacy in reducing inflammation and inhibiting the growth of cancer cells.

Advantages of Thalidomide:

1. Anti-Cancer Properties: Thalidomide is effective in treating multiple myeloma by slowing the growth of myeloma cells and inhibiting angiogenesis (formation of new blood vessels that supply tumors).
2. Immunomodulatory Effects: It enhances the immune system rsquo;s ability to fight cancer by altering the activity of the immune cells.
3. Treatment of Leprosy-Related Complications: It is highly effective in treating and preventing severe complications of leprosy, such as erythema nodosum leprosum.
4. Combination Therapy: Often used in combination with other medications like dexamethasone to increase the overall efficacy in treating multiple myeloma.
5. Reduces Inflammation: Its anti-inflammatory properties help manage immune system responses in various diseases.
6. Prevents Nerve Damage: Thalidomide has neuroprotective effects, which help prevent nerve damage in some conditions.

Uses of Thamid 50mg:

• Multiple Myeloma: Used in combination with other medications for the treatment of newly diagnosed multiple myeloma in patients who are not eligible for high-dose chemotherapy.
• Leprosy (Erythema Nodosum Leprosum): Prescribed for the treatment of moderate to severe skin complications of leprosy.
• Other Immune Disorders: Under investigation for its potential to treat other conditions that involve immune system dysregulation.

Tinib 0.89mg (Tivozanib Hydrochloride) is a potent VEGF receptor tyrosine kinase inhibitor manufactured by Pharma Lord, specifically designed to treat advanced renal cell carcinoma (RCC). Tivozanib Hydrochloride blocks the action of vascular endothelial growth factor (VEGF), a protein that stimulates the formation of blood vessels (angiogenesis) essential for tumor growth. By inhibiting VEGF receptors, Tivozanib cuts off the tumor's blood supply, slowing or stopping its growth.

Advantages of Tivozanib Hydrochloride:

1. Targeted Anti-Cancer Therapy: It specifically targets VEGF receptors, reducing tumor angiogenesis and growth, making it highly effective for kidney cancer.
2. Improved Progression-Free Survival: Clinical studies show Tivozanib extends progression-free survival in patients with advanced RCC compared to other treatments.
3. Fewer Side Effects: Tivozanib is generally well-tolerated with fewer side effects compared to other VEGF inhibitors, improving patients' quality of life.
4. Once-Daily Oral Administration: Its oral form provides ease of use and convenience for patients, reducing the need for frequent hospital visits.
5. Ideal for Long-Term Use: Its favorable safety profile makes it suitable for long-term therapy in treating renal cell carcinoma.

Uses of Tinib 0.89mg:

• Renal Cell Carcinoma (RCC): Tivozanib Hydrochloride is used for the treatment of advanced renal cell carcinoma, especially in patients who have not responded to other therapies.
• Monotherapy or Combination Therapy: It can be used as a stand-alone treatment or in combination with other cancer therapies to enhance treatment outcomes.

Topcan 1mg (Topotecan Hydrochloride) is an anti-cancer chemotherapy drug manufactured by Pharma Lord. Topotecan Hydrochloride belongs to the class of topoisomerase I inhibitors, which work by preventing cancer cells from properly repairing their DNA, leading to cell death. It is particularly effective in treating certain types of ovarian cancer, small cell lung cancer, and cervical cancer.

Advantages of Topotecan Hydrochloride:

1. Effective for Multiple Cancers: Topotecan is used to treat various cancers, including ovarian, small cell lung cancer, and cervical cancer, providing a broad spectrum of therapeutic action.
2. Targeted DNA Damage: As a topoisomerase I inhibitor, Topotecan specifically targets and damages cancer cells rsquo; DNA during replication, leading to tumor cell death.
3. Proven Survival Benefits: It has shown significant benefits in increasing survival rates, especially in patients with recurrent or persistent cancers.
4. Combination Therapy: Often used in combination with other chemotherapeutic agents to enhance the efficacy of cancer treatment.
5. Intravenous and Oral Forms: Available in both IV and oral formulations, offering flexibility in administration depending on the patient rsquo;s condition.

Uses of Topcan 1mg:

• Ovarian Cancer: Used to treat recurrent ovarian cancer after initial treatments have failed.
• Small Cell Lung Cancer: Effective for treating patients with small cell lung cancer who have relapsed or are not responsive to initial treatments.
• Cervical Cancer: Often used in combination with cisplatin to treat metastatic or recurrent cervical cancer.

Visgib 150mg (Vismodegib) is a targeted therapy drug manufactured by Pharma Lord, primarily used for treating advanced basal cell carcinoma (BCC). Vismodegib is a hedgehog pathway inhibitor that works by blocking a crucial signaling pathway (Hedgehog pathway) responsible for the growth and survival of cancer cells in BCC. By inhibiting this pathway, Vismodegib reduces tumor growth and promotes cancer cell death.

Advantages of Vismodegib:

1. Effective for Advanced BCC: Vismodegib is highly effective in treating locally advanced or metastatic basal cell carcinoma that cannot be treated with surgery or radiation.
2. Hedgehog Pathway Inhibition: It specifically targets and inhibits the Hedgehog signaling pathway, which is essential for the survival of certain cancer cells, leading to their destruction.
3. Oral Convenience: The drug is administered orally, providing convenience and ease of use for patients compared to other treatment options.
4. Minimal Invasive Option: Vismodegib offers a non-invasive treatment option for patients with advanced BCC, especially when surgery is not viable.
5. Promotes Tumor Shrinkage: It effectively shrinks basal cell carcinoma tumors, improving patient outcomes.

Uses of Visgib 150mg:

• Basal Cell Carcinoma (BCC): Primarily used for treating locally advanced or metastatic basal cell carcinoma in patients where surgery or radiation therapy is not suitable.
• Recurrent BCC: Effective in managing cases of recurrent basal cell carcinoma after prior treatments have failed.

Vomino 10mg by Pharma Lord is a trusted combination of Doxylamine and Pyridoxine (Vitamin B6), formulated to effectively relieve nausea and vomiting during pregnancy (NVP). Each pack contains 3 strips of 10 tablets (3 times;10 tablets), designed for safe and sustained symptom control.

Doxylamine, an antihistamine, works by reducing signals in the brain that trigger nausea, while Pyridoxine supports metabolic processes and helps ease morning sickness. Vomino is a safe and reliable choice for pregnant women seeking relief from nausea and vomiting.

Advantages:

• Proven effective in managing morning sickness.

• Safe for use during pregnancy under medical guidance.

• Combines antihistamine and vitamin support.

• Convenient 3 times;10 tablet packaging.

• Manufactured by Pharma Lord under stringent quality standards.

  Usages / Indications:

  • Treatment of nausea and vomiting in pregnancy (morning sickness).

  • Helps reduce the frequency and severity of nausea episodes.

  • Suitable for pregnant women when dietary and lifestyle changes are not sufficient.

Vorstat 100mg (Vorinostat) is a histone deacetylase (HDAC) inhibitor manufactured by Pharma Lord. Vorinostat is used primarily in the treatment of cutaneous T-cell lymphoma (CTCL), particularly in patients whose disease is persistent, progressive, or recurrent. It works by inhibiting the action of enzymes called histone deacetylases, which play a role in regulating gene expression. This inhibition leads to the reactivation of genes that suppress cancer cell growth, resulting in cancer cell death.

Advantages of Vorinostat:

1. Targeted Action: Vorinostat specifically targets histone deacetylases (HDACs), leading to the reactivation of tumor-suppressing genes and the inhibition of cancer cell growth.
2. Effective for CTCL: It is highly effective in managing cutaneous T-cell lymphoma, especially in patients whose disease is resistant to other treatments.
3. Promotes Cancer Cell Death: By affecting gene expression, Vorinostat helps to induce apoptosis (programmed cell death) in cancer cells.
4. Oral Administration: Vorinostat is available in oral form, providing ease of use and greater patient convenience.
5. Improves Quality of Life: It helps to manage symptoms and slow the progression of the disease, improving the overall quality of life in patients with CTCL.

Uses of Vorstat 100mg:

• Cutaneous T-cell Lymphoma (CTCL): Vorinostat is primarily used for the treatment of CTCL in patients who have failed to respond to other systemic therapies.
• Exploratory Use in Other Cancers: Vorinostat is being studied for potential use in other types of cancer, including non-Hodgkin lymphoma and solid tumors.

Zanib 80mg (Zanubrutinib) is a next-generation Bruton rsquo;s Tyrosine Kinase (BTK) inhibitor manufactured by Pharma Lord. It is primarily used to treat certain blood cancers, including mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL). Zanubrutinib works by inhibiting BTK, a protein essential for the growth and survival of cancerous B cells, leading to the death of these cancer cells.

Advantages of Zanubrutinib:

1. Selective BTK Inhibition: Zanubrutinib offers highly selective inhibition of BTK, reducing off-target effects and improving tolerability.
2. Efficacy in Blood Cancers: Proven effectiveness in treating blood cancers like mantle cell lymphoma and chronic lymphocytic leukemia, even in cases of relapse.
3. Improved Safety Profile: Compared to other BTK inhibitors, Zanubrutinib has a more favorable side effect profile, making it suitable for long-term treatment.
4. Oral Administration: Available as an oral capsule, allowing for convenient administration for patients.
5. Effective in High-Risk Patients: It has shown efficacy in treating high-risk patients and those resistant to other therapies.

Uses of Zanib 80mg:

• Mantle Cell Lymphoma (MCL): Zanubrutinib is indicated for the treatment of adult patients with mantle cell lymphoma who have received at least one prior therapy.
• Chronic Lymphocytic Leukemia (CLL): Used in the treatment of CLL and small lymphocytic lymphoma (SLL) to inhibit cancer cell growth.
• Waldenstr ouml;m rsquo;s Macroglobulinemia (WM): Also used for treating WM, a rare type of non-Hodgkin lymphoma.